Archit Organosys Limited reported a net profit of ₹1.45 crore for the first quarter of FY27 (Q1FY27), marking a 29% decline compared to ₹2.04 crore in the corresponding period of the previous fiscal year. Despite the dip in profitability, the company’s revenue from operations grew by 11.7% year-on-year to ₹37.08 crore, indicating sustained top-line momentum in its chemicals and organics segment.

The Board of Directors, chaired by Kandarp Amin, approved the unaudited financial results on August 12, 2026, following recommendations from the Audit Committee. The figures were reviewed by statutory auditors G. K. Choksi & Co., who issued a limited review report confirming compliance with Indian Accounting Standards (Ind AS) and SEBI Listing Regulations.

Financial Performance

Revenue from operations stood at ₹37.08 crore in Q1FY27, up from ₹33.20 crore in Q1FY26. However, other income decreased significantly to ₹0.60 crore from ₹0.99 crore in the prior year, contributing to a total income of ₹37.69 crore. Total expenses rose to ₹35.66 crore from ₹31.14 crore, primarily due to increased cost of materials consumed and purchases of stock-in-trade.

Profit before tax fell 33.3% to ₹2.03 crore, pressured by higher operational costs and tax expenses of ₹0.58 crore, up from ₹1.01 crore in the same quarter last year. Earnings per share (basic) declined to ₹0.71 from ₹0.99 in Q1FY26.

What the Numbers Show

The divergence between revenue growth and profit contraction highlights margin pressure in the current quarter. While top-line sales expanded by nearly 12%, total expenses grew at a faster rate of 14.5%, driven largely by a surge in material costs and inventory purchases. This suggests that input cost inflation or strategic stockpiling may have eroded operating margins, offsetting the benefits of higher sales volumes. Investors should monitor whether this margin compression persists as the company navigates evolving input cost dynamics.

Regulatory and Operational Notes

The company operates in a single reportable segment: Chemicals and Organics. It has no subsidiaries, associates, or joint ventures, making consolidated financial results inapplicable. Management noted that while the Government of India notified final Central Rules under the New Labour Codes during the quarter, the company assessed no material financial impact. It continues to monitor state-level rule finalization for any consequential adjustments.

The financial results were prepared in accordance with Ind AS and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board meeting commenced at 12:45 p.m. and concluded at 1:15 p.m. on August 12, 2026, in Ahmedabad.

Archit Organosys has reported its standalone audited financial results for the quarter and year ended March 31, 2026. The Board of Directors, at their meeting held on May 16, 2026, approved the results and recommended a final dividend of ₹1 per equity share (10%) of ₹10 each for the financial year ended March 31, 2026, subject to shareholder approval at the ensuing Annual General Meeting. The statutory auditors, M/s G.K. Choksi & Co., Chartered Accountants, issued an unmodified audit opinion on the standalone audited financial results. Subsequently, on May 18, 2026, the company filed a newspaper advertisement disclosure with BSE Limited under Regulation 30 read with Schedule III Part A Para A and Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, confirming that the audited financial statements were published in Western Times (English Edition) and Western Times (Gujarati Edition) on Sunday, May 17, 2026. The advertisement included a QR code and weblink to access the complete audited financial statements, which are also available on the company's website at www.architorg.com and on the BSE website.

Full Year Financial Performance

Archit Organosys delivered a strong performance for the full year ended March 31, 2026, with net profit rising sharply on the back of higher revenues and improved operating efficiency. The following table summarises the key annual financial metrics:

Expense Breakdown

Total expenses for FY26 stood at ₹13,284.46 lakh against ₹12,115.31 lakh in FY25. The detailed expense composition for the full year is presented below:

Quarterly Results Summary

For the quarter ended March 31, 2026, Archit Organosys reported a net profit of ₹202.22 lakh on total income of ₹3,602.88 lakh. This compares with a net profit of ₹201.75 lakh on total income of ₹4,424.75 lakh for the quarter ended March 31, 2025. Revenue from operations for the quarter stood at ₹3,649.89 lakh.

Balance Sheet Highlights

As at March 31, 2026, total assets stood at ₹12,667.17 lakh compared to ₹12,291.87 lakh as at March 31, 2025. Total equity improved to ₹7,623.27 lakh from ₹6,920.57 lakh, reflecting the accretion of profits during the year. Key balance sheet items are summarised below:

Within current assets, trade receivables stood at ₹2,454.84 lakh (FY25: ₹2,304.79 lakh), while cash and cash equivalents improved significantly to ₹137.41 lakh from ₹6.81 lakh. Non-current borrowings declined to ₹280.68 lakh from ₹448.79 lakh, reflecting debt repayment during the year.

Cash Flow Statement

The company generated net cash from operating activities of ₹268.46 lakh for FY26, compared to ₹1,852.01 lakh in FY25. Net cash from investing activities was ₹439.28 lakh, a reversal from the outflow of ₹2,084.73 lakh in FY25, primarily driven by inter-corporate deposit recoveries and interest received. Cash used in financing activities was ₹577.14 lakh against ₹142.77 lakh in FY25.

Dividend, Regulatory Disclosures and Other Information

The Board has recommended a final dividend of ₹1.00 per equity share (10% of face value of ₹10 each) for FY26, subject to shareholder approval at the ensuing Annual General Meeting. The company operates in a single reportable segment — Chemicals and Organics — in line with Ind AS 108. It has no subsidiary, associate, or joint venture, and hence consolidated financial results are not applicable. The paid-up equity share capital remains unchanged at ₹2,052.07 lakh.

In accordance with SEBI circular No. HO/38/13/1(2) 2026-MIRSD-POD/1/3750/2026 dated 30th January, 2026, a special window for transfer and dematerialisation of physical shares sold or purchased prior to April 01, 2019, has been opened for a period of one year from February 5, 2026 to February 4, 2027. This window is open only for re-lodgement of transfer deeds that were lodged prior to the deadline of April 1, 2019 and were rejected, returned, or not attended to due to deficiency in documents or process. Shares re-lodged for transfer will be issued only in demat mode under a lock-in of one year from the date of registration of transfer, and shall not be transferred, sold, or pledged during the lock-in period. Disputed cases and IEPF transferred shares are not eligible under this window. Shareholders may submit the required documents to the Registrar and Share Transfer Agent, MUFG Intime India Private Limited (formerly Link Intime India Pvt Ltd), C-101, Embassy 247, L B S Marg, Vikhroli (West), Mumbai – 400083.